In 2019, over 70 percent of British adults who were taking medicinal cannabidiol (CBD) products were doing so as a treatment for pain, by far the most common reason for taking CBD products in Great Britain. 38 percent were using CBD products for anxiety/depression while 24 percent were using these products as a treatment for sleeping disorders.
Share of reasons for the medicinal use of cannabidiol (CBD) products in Great Britain in 2019
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Statista Accounts:
Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.
YouGov. (October 18, 2019). Share of reasons for the medicinal use of cannabidiol (CBD) products in Great Britain in 2019 [Graph]. In Statista. Retrieved May 27, 2022, from https://www.statista.com/statistics/1093333/reasons-for-cbd-usage-in-great-britain/
YouGov. "Share of reasons for the medicinal use of cannabidiol (CBD) products in Great Britain in 2019." Chart. October 18, 2019. Statista. Accessed May 27, 2022. https://www.statista.com/statistics/1093333/reasons-for-cbd-usage-in-great-britain/
YouGov. (2019). Share of reasons for the medicinal use of cannabidiol (CBD) products in Great Britain in 2019. Statista. Statista Inc.. Accessed: May 27, 2022. https://www.statista.com/statistics/1093333/reasons-for-cbd-usage-in-great-britain/
YouGov. "Share of Reasons for The Medicinal Use of Cannabidiol (Cbd) Products in Great Britain in 2019." Statista, Statista Inc., 18 Oct 2019, https://www.statista.com/statistics/1093333/reasons-for-cbd-usage-in-great-britain/
YouGov, Share of reasons for the medicinal use of cannabidiol (CBD) products in Great Britain in 2019 Statista, https://www.statista.com/statistics/1093333/reasons-for-cbd-usage-in-great-britain/ (last visited May 27, 2022)